Reshema Kemps-Polanco serves as the Executive Vice President and Chief Commercial Officer for Novartis Pharmaceuticals Corporation in the US. In this role, she is responsible for the expansion of medicines across key therapeutic areas including oncology, immunology, neurology, and cardiovascular, renal, and metabolic diseases. She is focused on a transformational growth strategy aimed at sustaining Novartis's leading position in the US healthcare market.